Cutaneous adverse effects associated with LAG‐3 inhibitor use in cancer treatment: A systematic review

• Главные авторы: Hira Ghani (Автор), Samavia Khan (Автор), Marielle Jamgochian (Автор), Beth Richards (Автор), Erica DeCecco (Автор), Rebecca Fliorent (Автор), Nithisha Cheendalla (Автор), Khalil Khatri (Автор), Babar Rao (Автор)
• Формат: ‌
• Опубликовано: Wiley, 2023-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Immunotherapy has become a mainstay of treatment for many cancers. Multiple immune checkpoint inhibitors have been used to treat malignancies, including anti‐programed death‐1 (PD1) and anti‐cytotoxic T‐lymphocyte‐associated protein (anti‐CTLA4). However, a significant percentage of patient...